Leanne E. Henry
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Leanne E. Henry has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Laura S. Rozek
Georgetown University Medical Center, Department of Oncology, Washington, DC, USA
73 shared publications - Maureen A. Sartor
Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, USA
73 shared publications - Tingting Qin
Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan
73 shared publications - Bailey F. Garb
Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan
72 shared publications - Elysia Chou
Department of Computational Medicine and Bioinformatics, University of Michigan Medical School, Ann Arbor, Michigan
72 shared publications - Nisha J. D'SIlva
Periodontics and Oral Medicine, University of Michigan School of Dentistry, Ann Arbor, USA
72 shared publications
Latest Publications
- Open Access
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-031-031
Abstract PO-031: Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer
Background: Oral cavity squamous cell carcinoma (OCSCC) has an unpredictable response to immunotherapy, and standard biomarkers evaluating the tumor immune microenvironment (TIME) lack widespread translational applicability. Defining the TIME is critical to understanding mechanisms and allows the development of reproducible and accurate prognostic and predictive biomarkers based on immune profiles; however, to date, this remains elusive for clinical use. To further study and deconstruct the TIME within OCSCC, we integrated our previously developed computational spatial analysis (CSA) with in-silico deconvolution analyses to comprehensively study the TIME in OCSCC. Methods: We leveraged access to two independent OCSCC cohorts (UM and TCGA) with paired bulk RNASeq, WES, and CSA-immune score data. TMB, neoantigen load, and deconvolution analysis (CIBERSORTx) were performed to generate in silico immune profiles. A previously described CSA evaluates the density and distribution of tumor-infiltrating lymphocytes (TILs) relative to cancer cells to generate immune scores (GCross function [GFx]). GFx scores were then correlated with WES and RNASeq-derived cell-type deconvolution results, immune cell activation expression signatures, and gene expression-based radiosensitivity index scores. Pearson's correlation coefficient and associated p-value were calculated for each comparison. Cox proportional hazards multivariate regression was performed using the entire cohort for survival and recurrence analysis. Results: Here, we better characterize the immunologic tumor environment by objectively measuring the TIL density in spatial relationships with cancer cells. We found that immunoreactive tumors with high GFx scores are highly prognostic for overall survival, with the lowest tiers associated with poor survival. Combining the spatial relationship with immunogenomics (WES and RNASeq immune profiles) increased the prognostic capability of the integrated bioinformatics analysis model. In addition, we further revealed that lymphocyte-infiltrated regions, specifically CD8+ T-cells, are associated with TMB, neoantigen load, and improved overall survival. Conclusion: This study provides an integrated dataset from which to generate future insights and possible immunomodulatory therapies to counteract the poor immunogenicity of OCSCC. We show that integrating computational spatial analysis and in-silico deconvolution analysis is generalizable to multiple patient populations with different demographic compositions and pathology images collected from distinctive digitization methods. Our machine-learning approaches provide clinically actionable predictions that confirm the relevance of these biomarkers with immune cell infiltration and suggest the role of digital pathology profiling in predicting response to immunotherapy which could inform treatments for oral squamous carcinoma patients. Citation Format: Michael M. Allevato, Lisa Chionis, Joshua Smith, Santhoshi Krishnan, Leanne Henry, Tingting Qin, Janice Farlow, Laura Rozek, Jonathan Mchugh, Arvind Rao, Maureen Sartor, Steven B. Chinn. Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-031.
- 15 September 2023
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 29 (18_Supplem) , PO-031-031
Open AccessAbstract PO-031: Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer
Background: Oral cavity squamous cell carcinoma (OCSCC) has an unpredictable response to immunotherapy, and standard biomarkers evaluating the tumor immune microenvironment (TIME) lack widespread translational applicability. Defining the TIME is critical to understanding mechanisms and allows the development of reproducible and accurate prognostic and predictive biomarkers based on immune profiles; however, to date, this remains elusive for clinical use. To further study and deconstruct the TIME within OCSCC, we integrated our previously developed computational spatial analysis (CSA) with in-silico deconvolution analyses to comprehensively study the TIME in OCSCC. Methods: We leveraged access to two independent OCSCC cohorts (UM and TCGA) with paired bulk RNASeq, WES, and CSA-immune score data. TMB, neoantigen load, and deconvolution analysis (CIBERSORTx) were performed to generate in silico immune profiles. A previously described CSA evaluates the density and distribution of tumor-infiltrating lymphocytes (TILs) relative to cancer cells to generate immune scores (GCross function [GFx]). GFx scores were then correlated with WES and RNASeq-derived cell-type deconvolution results, immune cell activation expression signatures, and gene expression-based radiosensitivity index scores. Pearson's correlation coefficient and associated p-value were calculated for each comparison. Cox proportional hazards multivariate regression was performed using the entire cohort for survival and recurrence analysis. Results: Here, we better characterize the immunologic tumor environment by objectively measuring the TIL density in spatial relationships with cancer cells. We found that immunoreactive tumors with high GFx scores are highly prognostic for overall survival, with the lowest tiers associated with poor survival. Combining the spatial relationship with immunogenomics (WES and RNASeq immune profiles) increased the prognostic capability of the integrated bioinformatics analysis model. In addition, we further revealed that lymphocyte-infiltrated regions, specifically CD8+ T-cells, are associated with TMB, neoantigen load, and improved overall survival. Conclusion: This study provides an integrated dataset from which to generate future insights and possible immunomodulatory therapies to counteract the poor immunogenicity of OCSCC. We show that integrating computational spatial analysis and in-silico deconvolution analysis is generalizable to multiple patient populations with different demographic compositions and pathology images collected from distinctive digitization methods. Our machine-learning approaches provide clinically actionable predictions that confirm the relevance of these biomarkers with immune cell infiltration and suggest the role of digital pathology profiling in predicting response to immunotherapy which could inform treatments for oral squamous carcinoma patients. Citation Format: Michael M. Allevato, Lisa Chionis, Joshua Smith, Santhoshi Krishnan, Leanne Henry, Tingting Qin, Janice Farlow, Laura Rozek, Jonathan Mchugh, Arvind Rao, Maureen Sartor, Steven B. Chinn. Integrated bioinformatics and functional spatial analysis platform for the discovery of predictive biomarkers in oral cancer [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Innovating through Basic, Clinical, and Translational Research; 2023 Jul 7-8; Montreal, QC, Canada. Philadelphia (PA): AACR; Clin Cancer Res 2023;29(18_Suppl):Abstract nr PO-031.
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 1 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Companion figure showing significance results for main Figure 1D-F and Figure 2A.
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 1 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Companion figure showing significance results for main Figure 1D-F and Figure 2A.
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 3 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
DNA methylation-based gene set enrichment captures gene expression-based pathway-level differences. A, Dotplot for top 40 significant RNA enrichment terms, colored by −log10(P-value) illustrating enrichment results from RNA, DMRs across the whole genome, <5 kb from TSS, exons, and introns. B, Scatter plot for directional RNA and DNA methylation enrichment test results. Right quadrants represent significantly hypermethylated GO terms in IMU; top quadrants represent overexpressed terms in IMU. Red: terms significant with FDR < 0.05 for both methylation and expression. C–F, Specific genes’ visualization from paradigmatic GO terms, top: DNA methylation profile across gene body with 30% gene length flank regions. Gray lines: IMU versus KRT significant DMRs. Orange lines: Significant cis-eQTMs overlapped with DMRs, middle: differential 5hmc peaks in IMU versus KRT, bottom: bar plot for subgroups’ log2cpm expression value with edgeR FDR values. Color: subgroups.
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 3 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
DNA methylation-based gene set enrichment captures gene expression-based pathway-level differences. A, Dotplot for top 40 significant RNA enrichment terms, colored by −log10(P-value) illustrating enrichment results from RNA, DMRs across the whole genome, <5 kb from TSS, exons, and introns. B, Scatter plot for directional RNA and DNA methylation enrichment test results. Right quadrants represent significantly hypermethylated GO terms in IMU; top quadrants represent overexpressed terms in IMU. Red: terms significant with FDR < 0.05 for both methylation and expression. C–F, Specific genes’ visualization from paradigmatic GO terms, top: DNA methylation profile across gene body with 30% gene length flank regions. Gray lines: IMU versus KRT significant DMRs. Orange lines: Significant cis-eQTMs overlapped with DMRs, middle: differential 5hmc peaks in IMU versus KRT, bottom: bar plot for subgroups’ log2cpm expression value with edgeR FDR values. Color: subgroups.
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 2 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Average methylation of tumors and normal epithelial cells at gene body (A), promoter (B), CpG island (C) and repetitive region (D). Samples were grouped by HPVor HPV integration status.
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 2 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Average methylation of tumors and normal epithelial cells at gene body (A), promoter (B), CpG island (C) and repetitive region (D). Samples were grouped by HPVor HPV integration status.
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
TABLE 1 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
The total number of tested CpG 100-bp tiles and the number (percentage) of DMRs identified in each comparison
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessTABLE 1 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
The total number of tested CpG 100-bp tiles and the number (percentage) of DMRs identified in each comparison
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Supplementary Table S4- TFs and their ChIP-seq peak sets used
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Supplementary Table S4- TFs and their ChIP-seq peak sets used
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 6 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Methylation and expression visualization of the genes selected from the 108 genes previously reported as differentially methylated in HPV(+) compared to HPV(-) HNSCC.
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 6 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Methylation and expression visualization of the genes selected from the 108 genes previously reported as differentially methylated in HPV(+) compared to HPV(-) HNSCC.
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
FIGURE 6 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Inferred regulatory activity for genomic regions of interest differ between HNSCC subtypes and correlate with pathway scores. A, MIRA profile of CTCF binding sites in the NHEK cell line. Samples are colored by HPV(−), IMU, or KRT. B, Box plot displaying MIRA scores separated by subtype for CTCF binding sites, strong enhancers, and weak enhancers each from the NHEK cell line. C, Correlation between CTCF MIRA scores and gene expression–based keratinization scores with subtype shown by color. D, Box plot of MIRA scores by subtype for JunD, NFκB, and STAT3 binding sites each taken from different cell lines as indicated in the parentheses. E, Correlation between CTCF MIRA scores and JunD MIRA scores denoting subtype by color. Both scatter plots display the Pearson correlation coefficient (R) and corresponding P value. All P values < 0.05 are shown and P values < 0.00625 are considered significant. F, Box plot displaying gene expression values separated by subtype for transcription factors of interest. FDRs < 0.05 are indicated (*, FDR < 0.05; **, FDR < 0.01).
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessFIGURE 6 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Inferred regulatory activity for genomic regions of interest differ between HNSCC subtypes and correlate with pathway scores. A, MIRA profile of CTCF binding sites in the NHEK cell line. Samples are colored by HPV(−), IMU, or KRT. B, Box plot displaying MIRA scores separated by subtype for CTCF binding sites, strong enhancers, and weak enhancers each from the NHEK cell line. C, Correlation between CTCF MIRA scores and gene expression–based keratinization scores with subtype shown by color. D, Box plot of MIRA scores by subtype for JunD, NFκB, and STAT3 binding sites each taken from different cell lines as indicated in the parentheses. E, Correlation between CTCF MIRA scores and JunD MIRA scores denoting subtype by color. Both scatter plots display the Pearson correlation coefficient (R) and corresponding P value. All P values < 0.05 are shown and P values < 0.00625 are considered significant. F, Box plot displaying gene expression values separated by subtype for transcription factors of interest. FDRs < 0.05 are indicated (*, FDR < 0.05; **, FDR < 0.01).
- Open Access
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Supplementary Fig 3 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Comparison of locations of positive versus negative cis-eQTMs that overlap with DMRs for: IMU vs HPV(-) (1st row), IMU vs KRT (2nd row), and KRT vs HPV(-) (3rd row) of each panel. (A) CpG island annotations; (B) genic annotations. 1st and 2nd columns are hypermethylated in the first comparison group; 3rd and 4th columns are hypomethylated in the first comparison group. Negative eQTMs are in the 1st and 3rd columns, while positive eQTMs are in the 2nd and 4th columns.
- 30 August 2023
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Fig 3 from Whole-genome CpG-resolution DNA Methylation Profiling of HNSCC Reveals Distinct Mechanisms of Carcinogenesis for Fine-scale HPV+ Cancer Subtypes
Comparison of locations of positive versus negative cis-eQTMs that overlap with DMRs for: IMU vs HPV(-) (1st row), IMU vs KRT (2nd row), and KRT vs HPV(-) (3rd row) of each panel. (A) CpG island annotations; (B) genic annotations. 1st and 2nd columns are hypermethylated in the first comparison group; 3rd and 4th columns are hypomethylated in the first comparison group. Negative eQTMs are in the 1st and 3rd columns, while positive eQTMs are in the 2nd and 4th columns.